Clinical Trial Update: Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Therapy Using 1,064 nm and 595 nm [NA]

View source ↗

Summary

Clinical trial update reports on the efficacy and safety of a picosecond Nd:YAG laser therapy for melasma (1,064 nm and 595 nm).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Picosecond Nd:YAG laser therapy (1,064 nm and 595 nm)

Snippet

Sponsor: CynosureLutronic | Conditions: Melasma | NA | Status: COMPLETED